• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study.非酒精性脂肪性肝病对北方城市汉族人群代谢综合征的预测:一项前瞻性队列研究。
PLoS One. 2014 May 6;9(5):e96651. doi: 10.1371/journal.pone.0096651. eCollection 2014.
2
Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.代谢综合征及其组分作为中国北方城市汉族人群非酒精性脂肪性肝病预测因素的前瞻性队列研究
Atherosclerosis. 2015 May;240(1):144-8. doi: 10.1016/j.atherosclerosis.2015.02.049. Epub 2015 Mar 11.
3
The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.非酒精性脂肪性肝病作为代谢综合征在韩国男性中早期预测指标的临床可用性:一项为期 5 年的前瞻性队列研究。
Atherosclerosis. 2013 Apr;227(2):398-403. doi: 10.1016/j.atherosclerosis.2013.01.002. Epub 2013 Jan 18.
4
Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.非肥胖中国人群胰岛素抵抗指数代谢评分与非酒精性脂肪性肝病的剂量-反应关系:基于人群队列研究的回顾性证据。
Dis Markers. 2022 Feb 23;2022:4930355. doi: 10.1155/2022/4930355. eCollection 2022.
5
Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study.中国城市汉族人群白细胞计数与非酒精性脂肪性肝病的关联:一项前瞻性队列研究
BMJ Open. 2016 Jun 1;6(6):e010342. doi: 10.1136/bmjopen-2015-010342.
6
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.非酒精性脂肪性肝病(NAFLD)、代谢综合征与心房颤动中的心血管事件。一项前瞻性多中心队列研究。
Intern Emerg Med. 2021 Nov;16(8):2063-2068. doi: 10.1007/s11739-021-02682-3. Epub 2021 Mar 13.
7
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.瘦型非酒精性脂肪性肝病增加了正常体重中国人群发生代谢紊乱的风险。
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.
8
Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.通过简化贝叶斯网络在中国人群中识别非酒精性脂肪性肝病与代谢综合征之间的相互因果关系。
BMJ Open. 2015 Sep 22;5(9):e008204. doi: 10.1136/bmjopen-2015-008204.
9
Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome.非酒精性脂肪性肝病对代谢综合征个体糖尿病发生的叠加效应。
Diabetes Res Clin Pract. 2017 Jul;129:136-143. doi: 10.1016/j.diabres.2017.03.037. Epub 2017 May 5.
10
Self-reported snoring is associated with nonalcoholic fatty liver disease.自述打鼾与非酒精性脂肪性肝病有关。
Sci Rep. 2020 Jun 9;10(1):9267. doi: 10.1038/s41598-020-66208-1.

引用本文的文献

1
Unveiling the Hepatic Harbinger: Assessing the Fatty Liver Index as a Predictor of Metabolic Syndrome in Female Healthcare Workers.揭示肝脏预兆:评估脂肪肝指数作为女性医护人员代谢综合征的预测指标
Indian J Occup Environ Med. 2024 Oct-Dec;28(4):293-297. doi: 10.4103/ijoem.ijoem_54_24. Epub 2024 Dec 23.
2
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中心血管疾病风险的综合综述
J Cardiovasc Dev Dis. 2022 Nov 26;9(12):419. doi: 10.3390/jcdd9120419.
3
Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns.非酒精性脂肪肝与不同体型表型在基线和变化模式中代谢健康恶化的相关性。
Sci Rep. 2022 Aug 30;12(1):14786. doi: 10.1038/s41598-022-18988-x.
4
Machine learning-aided risk prediction for metabolic syndrome based on 3 years study.基于 3 年研究的机器学习辅助代谢综合征风险预测。
Sci Rep. 2022 Feb 10;12(1):2248. doi: 10.1038/s41598-022-06235-2.
5
Tobacco, Cigarettes, and the Liver: The Smoking Gun.烟草、香烟与肝脏:确凿证据
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):700-712. doi: 10.1016/j.jceh.2021.07.016. Epub 2021 Aug 10.
6
Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的心脏代谢紊乱。
Int J Mol Sci. 2019 May 6;20(9):2215. doi: 10.3390/ijms20092215.
7
Association between smoking and non-alcoholic fatty liver disease: A systematic review and meta-analysis.吸烟与非酒精性脂肪性肝病之间的关联:一项系统评价和荟萃分析。
SAGE Open Med. 2018 Jan 24;6:2050312117745223. doi: 10.1177/2050312117745223. eCollection 2018.
8
Bi-directional analysis between fatty liver and cardiovascular disease risk factors.脂肪肝与心血管疾病危险因素之间的双向分析
J Hepatol. 2017 Feb;66(2):390-397. doi: 10.1016/j.jhep.2016.09.022. Epub 2016 Oct 10.
9
Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?非酒精性脂肪性肝病患者中使用受控衰减参数的瞬时弹性成像(FibroScan(®))评估肝脏脂肪变性和纤维化——我们目前的进展如何?
World J Gastroenterol. 2016 Aug 28;22(32):7236-51. doi: 10.3748/wjg.v22.i32.7236.
10
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.非酒精性脂肪性肝病与代谢综合征的关联独立于中心性肥胖和胰岛素抵抗。
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.

本文引用的文献

1
Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies.中国大陆非酒精性脂肪性肝病的患病率:已发表研究的荟萃分析。
J Gastroenterol Hepatol. 2014 Jan;29(1):42-51. doi: 10.1111/jgh.12428.
2
The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.非酒精性脂肪性肝病作为代谢综合征在韩国男性中早期预测指标的临床可用性:一项为期 5 年的前瞻性队列研究。
Atherosclerosis. 2013 Apr;227(2):398-403. doi: 10.1016/j.atherosclerosis.2013.01.002. Epub 2013 Jan 18.
3
Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups.非酒精性脂肪性肝病作为代谢综合征的一种独立表现:三个种族的美国全国性调查结果。
J Gastroenterol Hepatol. 2013 Apr;28(4):664-70. doi: 10.1111/jgh.12106.
4
Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.韩国成年人中,根据体重指数,非酒精性脂肪性肝病与代谢综合征各组分的关系。
Am J Gastroenterol. 2012 Dec;107(12):1852-8. doi: 10.1038/ajg.2012.314. Epub 2012 Oct 2.
5
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?非酒精性脂肪性肝病:一个新的重要心血管风险因素?
Eur Heart J. 2012 May;33(10):1190-200. doi: 10.1093/eurheartj/ehr453. Epub 2012 Mar 8.
6
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的心血管疾病风险
N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063.
7
Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome.非酒精性脂肪性肝病:代谢综合征的肝脏触发因素。
J Hepatol. 2010 Dec;53(6):1146-7. doi: 10.1016/j.jhep.2010.06.013. Epub 2010 Aug 13.
8
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.非酒精性脂肪性肝病作为糖尿病和代谢综合征发生的危险因素:一项为期11年的随访研究。
Am J Gastroenterol. 2009 Apr;104(4):861-7. doi: 10.1038/ajg.2009.67. Epub 2009 Mar 17.
9
Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.印度南部城市非酒精性脂肪性肝病的患病率与不同程度的葡萄糖不耐受和代谢综合征的关系。
Diabetes Res Clin Pract. 2009 Apr;84(1):84-91. doi: 10.1016/j.diabres.2008.11.039. Epub 2009 Jan 24.
10
Epidemiology of non-alcoholic fatty liver disease in China.中国非酒精性脂肪性肝病的流行病学
J Hepatol. 2009 Jan;50(1):204-10. doi: 10.1016/j.jhep.2008.10.010. Epub 2008 Nov 6.

非酒精性脂肪性肝病对北方城市汉族人群代谢综合征的预测:一项前瞻性队列研究。

Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study.

作者信息

Zhang Tao, Zhang Yongyuan, Zhang Chengqi, Tang Fang, Li Hongkai, Zhang Qian, Lin Haiyan, Wu Shuo, Liu Yanxun, Xue Fuzhong

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Shandong University, Jinan, China.

Medical Department,Qilu Hospital of Shandong University, Jinan, China.

出版信息

PLoS One. 2014 May 6;9(5):e96651. doi: 10.1371/journal.pone.0096651. eCollection 2014.

DOI:10.1371/journal.pone.0096651
PMID:24801211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4011868/
Abstract

OBJECTIVES

To explore the relationship between non-alcoholic fatty liver disease (NAFLD) and the metabolic syndrome (MetS), and evaluate the value of NAFLD as a marker for predicting the risk of MetS in a large scale prospective cohort from northern urban Han Chinese population.

MATERIALS AND METHODS

A total of 17,920 MetS-free at baseline cohort members was included in the current study between 2005 and 2011. The baseline characteristics of the cohort were compared by NAFLD status at baseline, MetS status after follow-up. Cox proportional hazards models were used to estimate the unadjusted or adjusted hazard ratios (HRs) for NAFLD at baseline predicting the risk of MetS.

RESULTS

2,183 (12.18%) new cases of MetS occurred between 2005 and 2011. In unadjusted model, HRs (95% CIs) for NAFLD predicting MetS was 3.65 (3.35, 3.97). After adjusting the confounding factors of age, gender, the metabolic factors, smoke and exercise, the HRs (95% CIs) was 1.70 (1.55, 1.87). Gender difference was observed, adjusted HRs (95% CIs) of NAFLD for predicting MetS were 2.06(1.72, 2.46) and 1.55(1.39, 1.72) in female and male population, respectively. Moreover, 163 participants developed MetS among participants without any MetS component at baseline, and its adjusted HRs was still significant, 1.87 (1.12, 3.13).

CONCLUSION

The present study indicates that NAFLD is an independent risk factor for predicting the risk of MetS in northern urban Han Chinese population, and the people with NAFLD should initiate weight and dietary control to prevent the occurrence of MetS.

摘要

目的

探讨非酒精性脂肪性肝病(NAFLD)与代谢综合征(MetS)之间的关系,并评估在北方城市汉族大规模前瞻性队列中,NAFLD作为预测MetS风险标志物的价值。

材料与方法

2005年至2011年期间,本研究共纳入17920名基线时无MetS的队列成员。根据基线时的NAFLD状态、随访后的MetS状态比较队列的基线特征。采用Cox比例风险模型估计基线时NAFLD预测MetS风险的未调整或调整风险比(HRs)。

结果

2005年至2011年期间,共出现2183例(12.18%)新的MetS病例。在未调整模型中,NAFLD预测MetS的HRs(95%CI)为3.65(3.35,3.97)。在调整年龄、性别、代谢因素、吸烟和运动等混杂因素后,HRs(95%CI)为1.70(1.55,1.87)。观察到性别差异,女性和男性人群中NAFLD预测MetS的调整HRs(95%CI)分别为2.06(1.72,2.46)和1.55(1.39,1.72)。此外,163名参与者在基线时无任何MetS组分,随访期间发生了MetS,其调整后的HRs仍具有统计学意义,为1.87(1.12,3.13)。

结论

本研究表明,NAFLD是北方城市汉族人群预测MetS风险的独立危险因素,NAFLD患者应开始控制体重和饮食,以预防MetS的发生。